766 related articles for article (PubMed ID: 12740479)
21. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
[TBL] [Abstract][Full Text] [Related]
22. [Immune factors in atherosclerosis].
Pasqui AL; Bova G; Maffei S; Auteri A
Ann Ital Med Int; 2005; 20(2):81-9. PubMed ID: 16052840
[TBL] [Abstract][Full Text] [Related]
23. Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase.
Kaplan M; Aviram M
Clin Chem Lab Med; 1999 Aug; 37(8):777-87. PubMed ID: 10536926
[TBL] [Abstract][Full Text] [Related]
24. [The role of LDL in the origin and progression of atherosclerosis: pathobiological concepts on the origin and development of atherosclerotic lesions and the role of the endothelium].
De Caterina R; Lenzi S
G Ital Cardiol; 1998 Feb; 28(2):158-67. PubMed ID: 9534057
[TBL] [Abstract][Full Text] [Related]
25. Role of monocytes in atherogenesis.
Osterud B; Bjorklid E
Physiol Rev; 2003 Oct; 83(4):1069-112. PubMed ID: 14506301
[TBL] [Abstract][Full Text] [Related]
26. Hyperlipoproteinaemia and atherosclerosis in rabbits fed low-level cholesterol and lecithin.
Hunt CE; Duncan LA
Br J Exp Pathol; 1985 Feb; 66(1):35-46. PubMed ID: 3970829
[TBL] [Abstract][Full Text] [Related]
27. Atherosclerosis as an inflammatory disease.
Tuttolomondo A; Di Raimondo D; Pecoraro R; Arnao V; Pinto A; Licata G
Curr Pharm Des; 2012; 18(28):4266-88. PubMed ID: 22390643
[TBL] [Abstract][Full Text] [Related]
28. A modern view of atherogenesis.
Schwartz CJ; Valente AJ; Sprague EA
Am J Cardiol; 1993 Feb; 71(6):9B-14B. PubMed ID: 8434561
[TBL] [Abstract][Full Text] [Related]
29. The pathogenesis of atherosclerosis: atherogenesis and inflammation.
Munro JM; Cotran RS
Lab Invest; 1988 Mar; 58(3):249-61. PubMed ID: 3279259
[TBL] [Abstract][Full Text] [Related]
30. The process of atherogenesis--cellular and molecular interaction: from experimental animal models to humans.
Ross R; Agius L
Diabetologia; 1992 Dec; 35 Suppl 2():S34-40. PubMed ID: 1478376
[TBL] [Abstract][Full Text] [Related]
31. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
Chapman MJ; Guérin M; Bruckert E
Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
[TBL] [Abstract][Full Text] [Related]
32. Recent developments in atherogenesis.
Stein O; Stein Y
Arzneimittelforschung; 1990 Mar; 40(3A):348-50. PubMed ID: 2185761
[TBL] [Abstract][Full Text] [Related]
33. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
Staprans I; Pan XM; Rapp JH; Feingold KR
Mol Nutr Food Res; 2005 Nov; 49(11):1075-82. PubMed ID: 16270280
[TBL] [Abstract][Full Text] [Related]
34. Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase.
Shimada M; Ishibashi S; Inaba T; Yagyu H; Harada K; Osuga JI; Ohashi K; Yazaki Y; Yamada N
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7242-6. PubMed ID: 8692976
[TBL] [Abstract][Full Text] [Related]
35. Induction of atherosclerosis by human chylomicron remnants: a hypothesis.
Wilhelm MG; Cooper AD
J Atheroscler Thromb; 2003; 10(3):132-9. PubMed ID: 14564081
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
[TBL] [Abstract][Full Text] [Related]
37. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
Boullier A; Hennuyer N; Tailleux A; Furman C; Duverger N; Caillaud JM; Castro G; Fievet C; Fruchart JC; Duriez P
Clin Sci (Lond); 2001 Mar; 100(3):343-55. PubMed ID: 11222122
[TBL] [Abstract][Full Text] [Related]
38. [Cellular and molecular biology of atherosclerotic lesions].
Martínez-González J; Llorente-Cortés V; Badimon L
Rev Esp Cardiol; 2001 Feb; 54(2):218-31. PubMed ID: 11181311
[TBL] [Abstract][Full Text] [Related]
39. Cytokines, immuno-inflammatory response and atherosclerosis.
Tedgui A; Bernard C
Eur Cytokine Netw; 1994; 5(3):263-70. PubMed ID: 7948763
[TBL] [Abstract][Full Text] [Related]
40. [The role of immune inflammation in atherogenesis].
Nagornev VA; Rabinovich VS
Vopr Med Khim; 1997; 43(5):339-48. PubMed ID: 9446324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
